A purple and pink letter v on a white background.
October 27, 2021

Navigate Through the Complexities of Female Hair Loss

Hair restoration is an exciting and lucrative segment of the aesthetics industry and a robust addition to any clinic s offerings. Although hair loss affects both men and women, each demographic has unique needs that you must acknowledge and address in order to cater to the growing demand for this life-changing treatment. Below, we explore the complexities of female hair loss in today s market that you need to know for your clinic s success.  

Overview Of the Female Hair Restoration Market

 

 The total market for hair restoration treatments  has increased 16% since 2016  and it is now a $4.9 billion industry. Last year alone, over 700,000 procedures were performed worldwide. The same  International Society of Hair Restoration Surgery  reports that only 16% of those procedures were performed on women, a number which allows us to draw three conclusions. First, that women spent approximately $784 million on hair restoration last year. Second, that the market is growing, up from just 12% the previous year. Third, that there is still hesitation among women to get a hair restoration procedure, which could be due to the simple fact that hair restoration is still, in large part, marketed solely to men. From this, we can expect that any clinic that puts effort into marketing hair restoration towards women will have the advantage of attracting an overlooked demographic.  

 

COVID-19 And Female Hair Loss    

Female hair los s can be due to a variety of factors, including genetics, lifestyle changes, certain medications, or post-pregnancy. In some cases, the hair loss is temporary. In cases where the hair loss is permanent, only a hair restoration procedure will revive   the lost hair. Recently,  studies have shown  that women who have had COVID-19 are experiencing hair loss for months after recovering from the virus. Anecdotal reports from recovering patients, including  celebrities like Alyssa Milano , further these claims. For now, it appears that post-COVID-19 has to do with the three stages of hair growth and that the shedding may be temporary, with the hair returning to normal growth after a period of time. However, COVID-19 hair loss brings up an opportunity to open up a discussion about female hair loss, and to invite women into your clinic to discuss their concerns. If their hair loss is more severe, permanent, or continues long after COVID-19, then a hair restoration procedure is the answer.     

The Emotional Impact of Female Hair Loss

According to  one study by the American Academy of Dermatology , 40% of women will experience noticeable hair loss by the age of 40 . It isn t difficult to imagine the toll that female hair loss can take on self-esteem. In many cultures, a full head of hair denotes not only good health, but also social status, youth, and beauty. In men, hair loss takes such a huge bite out of confidence that  it has been shown to affect self-perception and interpersonal relationships for women it s no different. This is  reflected in a survey  uncovering that the most common reasons for patients  seeking hair restoration among patients were  social/dating ’  (37%), followed by  career/professional ’  (34%).  Because female hair loss can have such an impact on self-esteem, saying that hair restoration can be life-changing is no overstatement.   

The Solution  

M any women experiencing hair  loss or  thinning  thinking that  over-the-counter options  or styling their hair differently are their only options.   This is because most  hair loss solutions are marketed to men .  With  the stigma of hair loss and a lack of  clear marketing female patients  are  at a disadvantage when searching for someone to turn to for advice.  That s why positioning your clinic as an expert in female hair restoration could put you at an advantage over your competitors. There is a better option for permanent hair restoration specifically designed with female hair loss in mind:  NeoGraft ® .    

NeoGraft ®  is the latest generation in hair restoration devices, using automated FUE in a process that requires no stitches, leaves no visible scarring, and delivers a more natural-looking result. The procedure uses your own existing hair, transplanting healthy follicles through precision  micrografts  that cause little to no discomfort during the procedure, and require little downtime. After some initial tenderness in the first 2-3 days, most people return to regular activities. The transplanted hair will look natural, grow at the same rate as the surrounding hair, and  should last for life .  

Recently, we followed  Jessi s journey  as she underwent a  NeoGraft ®  hair restoration procedure. Her experience sums up what we ve learned about the complexities of female hair loss. When she began to notice her hair thinning after having children, she turned to over-the-counter and styling to cover it up.  I tried vitamins, shampoos, spray fibers all of that stuff only helps the hair you have. It doesn t grow new hair. ”  That s when her friend  recommended,  she  look into hair restoration, and she   found out about   NeoGraft ® .  As little as  18 months  after the procedure,  she booked her first  salon  appointment  in ages Now that my hair is all grown, I feel like I can do any hairstyle. People are telling me how awesome and full my hair looks .  

You can offer the same transformative experience that Jessi experienced with  NeoGraft  to your patients. Reach out to one of our experts today to learn more.   

By Yoni Nowmalki July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.